<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The goals of this study were to 1) determine the <z:hpo ids='HP_0011009'>acute</z:hpo> effect of ANG-(1-7) on vascular tone in isolated middle cerebral arteries (<z:chebi fb="70" ids="34342">MCAs</z:chebi>) from Sprague-Dawley rats fed a <z:mpath ids='MPATH_458'>normal</z:mpath> salt (NS; 0.4% <z:chebi fb="1" ids="26710">NaCl</z:chebi>) diet, 2) evaluate the ability of <z:hpo ids='HP_0011010'>chronic</z:hpo> intravenous infusion of ANG-(1-7) (4 ng路kg(-1)路min(-1)) for 3 days to restore endothelium-dependent dilation to <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> (<z:chebi fb="0" ids="15355">ACh</z:chebi>) in rats fed a high-salt (HS; 4% <z:chebi fb="1" ids="26710">NaCl</z:chebi>) diet, and 3) determine whether the amelioration of <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> by ANG-(1-7) infusion in rats fed a HS diet is different from the protective effect of low-dose ANG II infusion in salt-fed rats </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="70" ids="34342">MCAs</z:chebi> from rats fed a NS diet dilated in response to exogenous ANG-(1-7) (10(-10)-10(-5) M) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> ANG-(1-7) infusion significantly reduced vascular <z:chebi fb="1" ids="18421">superoxide</z:chebi> levels and restored the nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>-dependent dilation to <z:chebi fb="0" ids="15355">ACh</z:chebi> (10(-10)-10(-5) M) that was lost in <z:chebi fb="70" ids="34342">MCAs</z:chebi> of rats fed a HS diet </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> vasodilation to ANG-(1-7) and the restoration of <z:chebi fb="0" ids="15355">ACh</z:chebi>-induced dilation by <z:hpo ids='HP_0011010'>chronic</z:hpo> ANG-(1-7) infusion in rats fed a HS diet were blocked by the Mas receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> [D-ALA(7)]-ANG-(1-7) or the ANG II type 2 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>-123319 and unaffected by ANG II type 1 receptor blockade with <z:chebi fb="0" ids="6541">losartan</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>The restoration of <z:chebi fb="0" ids="15355">ACh</z:chebi>-induced dilation in <z:chebi fb="70" ids="34342">MCAs</z:chebi> of HS-fed rats by <z:hpo ids='HP_0011010'>chronic</z:hpo> intravenous infusion of ANG II (5 ng路kg(-1)路min(-1)) was blocked by <z:chebi fb="0" ids="6541">losartan</z:chebi> and unaffected by d-ALA </plain></SENT>
<SENT sid="5" pm="."><plain>These findings demonstrate that circulating ANG-(1-7), working via the Mas receptor, restores endothelium-dependent vasodilation in cerebral resistance arteries of animals fed a HS diet via mechanisms distinct from those activated by low-dose ANG II infusion </plain></SENT>
</text></document>